Skip to main content

Table 3 Meta Regression for subgroups of relapse free patients

From: Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

Variables

Coef.

Std. Err.

z

P > |z|

[95% Conf. Interval]

Study type

−0.7796787

0.1653799

−4.17

< 0.001

−1.103817 .920804

Duration of followup

−0.208344

0.0071029

−2.93

0.003

−.0347557–.006913

AQP-4 positivity

0.0030413

0.0024175

1.26

0.208

−.0016968 .0077795

Site of injection

0.5235

0.1142147

4.58

< 0.001

.2996432 .7473567

_cons

0.6510876

0.2339978

2.78

0.005

−.1924603 1.109715